T1	Participants 35 59	malaria chemoprophylaxis
T2	Participants 161 277	users of malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine)
T3	Participants 292 332	nonimmune tourists to sub-Saharan Africa
T4	Participants 445 477	Switzerland, Germany, and Israel
T5	Participants 536 544	(n= 547)
T6	Participants 1461 1476	median age 34 y
